El-Hitti v. Americare Kidney Inst., L.L.C.
Opinion
COURT OF APPEALS OF OHIO
EIGHTH APPELLATE DISTRICT COUNTY OF CUYAHOGA
WASSIM EL-HITTI, ET AL., :
Plaintiffs-Appellants, :
No. 113650
v. :
AMERICARE KIDNEY INSTITUTE, LLC, ET AL., :
Defendants-Appellees. :
JOURNAL ENTRY AND OPINION
JUDGMENT: AFFIRMED AND REMANDED RELEASED AND JOURNALIZED: January 23, 2025
Civil Appeal from the Cuyahoga County Common Pleas Court Case No. CV-21-955156
Appearances:
Amundsen Davis, LLC, Christopher B. Congeni, Christopher R. Green, and Marissa R. Borschke, for appellants.
Lewis Brisbois Bisgaard & Smith, LLP, John F. Hill, and Meleah M. Skillern, for appellee.
ANITA LASTER MAYS, J.:
{¶1} Plaintiffs-appellants Drs. Wassim El-Hitti, Akhilesh Rao, and Saurabh Bansal, collectively known as (“the appellants”), appeal the trial court’s decision denying their motion to bifurcate the compensatory and punitive damages portions of the ongoing trial. We affirm the trial court’s decision to deny the appellants’ motion to bifurcate the compensatory and punitive damages portions of the breach-of-fiduciary and unfair-competition claims and remand for further proceedings. I. Facts and Procedural History
{¶2} On November 1, 2021, the appellants filed a complaint against defendant-appellee Americare Kidney Institute, LLC (“AKI”) alleging that AKI was involved in perpetuating fraudulent billing practices. The appellants argued that as a result of AKI’s alleged fraud, their professional reputations were affected and requested that AKI release the appellants from their restrictive covenants. AKI refused the appellants’ request, and the appellants filed suit against AKI for breach of contract, fraud, and a declaratory judgment that the noncompete clause contained in their agreements was unreasonable as a matter of law.
{¶3} The appellants also alleged that AKI, under the previous CEO, launched an investigation into the participants engaging in the fraudulent billing practices. However, the previous CEO was fired and replaced with Dr. Keith Petras (“Dr. Petras”), who halted the investigation and refused to release the limited report generated from the investigation. In response to the appellants’ complaint, AKI filed a counterclaim against the appellants for unfair competition, breach of contract, and breach of fiduciary duty.
{¶4} On October 23, 2023, the appellants filed a motion to bifurcate on issues of compensatory and punitive or exemplary damages. In the appellants’ motion, they argued that the plain language of R.C. 2315.21(B) creates no ambiguity regarding its application that a trial court, on the motion of any party, is required to bifurcate a tort action to allow presentation of the claims for compensatory and punitive damages in separate stages. The appellants moved the trial court to bifurcate the trial in this matter because two of AKI’s counterclaims, breach of fiduciary duty and unfair competition, sought an award of punitive damages. As such, the appellants moved the trial court for an order prohibiting AKI from presenting any evidence or argument on the issue of punitive or exemplary damages in the compensatory damages stage of the proceedings.
{¶5} On February 15, 2024, the trial court denied the appellants’ motion stating in its journal entry, in part:
The declaratory judgment claim unquestionably falls outside the mandates of R.C. 2315.21. However, plaintiffs claim R.C. 2315.21 requires this court to bifurcate the jury trial in this matter on the remaining substantive claims, as they relate to issues of compensatory and punitive damages.
R.C. 2315.21 requires bifurcation in “tort actions” defined as a “a civil action for damages for injury or loss to person or property” and specifically including product liability and employment discrimination claims. Notably, the statute excludes civil actions for breach of contract or other agreement between persons. By the statutes own language, the claim for breach of the operating agreement clearly falls outside the purview of R.C. 2315.21 as a breach of contract claim.
Regarding the fiduciary duty claim, the court agrees with the analysis in Kramer Consulting, Inc. v. McCarthy, 2006 U.S. Dist. LEXIS 12857 (S.D. Ohio Mar. 8, 2006) and its progeny, and does not find R.C. 2315.21 applicable, citing to Chapter 1701, that court held that “the Ohio Legislature clearly did not intend to include a breach of fiduciary claim . . . within the purview of the ‘Tort Reform III’ statute.
. . . R.C. 2315.21 is inapplicable to plaintiff’s claim.” Id. at *8.
The remaining claim is one of unfair competition, the elements of which do not sound in negligence and require proof of malicious conduct. The court finds this claim also falls outside the purview of R.C. 2315.21. Further, proof of unfair competition will necessarily require identical evidence as that in support of any claim for punitive damages, pursuant to the standard in R.C. 2315.21(C)(1) (malice, aggravated or egregious fraud, knowing authorization or ratification).
Accordingly, judicial economy is served by proceeding with one trial on [this] matter.
Plaintiffs/Counterclaim defendants’ motion to bifurcate is denied.
Journal Entry No. 174529693 (Feb. 15, 2024).
{¶6} On February 19, 2024, the appellants filed a notice of appeal, and the trial court ordered a stay in the proceedings pending the outcome of this appeal. The appellants assigned one error for our review:
The trial court erred as a matter of law by failing to bifurcate the jury trial on plaintiffs-appellants’ motion to bifurcate on issues of compensatory and punitive or exemplary damages pursuant to the mandate of R.C. 2315.21.
II. Standard of Review
{¶7} “We review a denial of a motion to bifurcate claims or issues for trial under an abuse-of-discretion standard.” Pingue v. Preferred Real Estate Invests. II, LLC, 2015-Ohio-4751, ¶ 84 (5th Dist.), citing Amerifirst Savs. Bank of Xenia v.
Krug, 136 Ohio App.3d 468, 485 (2d Dist. 1999). An abuse of discretion occurs when a court exercises its judgment in an unwarranted way regarding a matter over which it has discretionary authority. Johnson v. Abdullah, 2021-Ohio-3304,
¶ 35. III. Law and Analysis
{¶8} In the appellants’ sole assignment of error they argue two issues. First, that breach-of-fiduciary-duty claims and unfair-competition-by-malicious- litigation claims are tort actions as defined by R.C. 2315.21; and second, the trial court committed reversible error when it denied the appellants’ motion to bifurcate compensatory and punitive damages in a tort action upon the motion of a party.
{¶9} “Under R.C. 2315.21(B), the trial court has no discretion to deny a motion to bifurcate the punitive damages issue in a tort case when a party files a motion requesting bifurcation.” Flynn v. Fairview Village Retirement, 2013- Ohio-569, ¶ 6 (8th Dist.), citing Havel v. Villa St. Joseph, 2012-Ohio-552, ¶ 26. “Indeed, ‘R.C. 2315.21(B) creates a substantive right to bifurcation in tort actions when claims for compensatory and punitive damages have been asserted.’” Id., quoting id. at ¶ 36.
{¶10} R.C. 2315.21(A) defines tort actions as the following:
(1) “Tort action” means a civil action for damages for injury or loss to person or property.
(a) “Tort action” includes all of the following:
(i) A product liability claim for damages for injury or loss to person or property that is subject to sections 2307.71 to 2307.80 of the Revised Code;
(ii) A civil action based on an unlawful discriminatory practice relating to employment brought under section 4112.052 of the Revised Code;
(iii) A civil action brought under section 4112.14 of the Revised Code.
Free access — add to your briefcase to read the full text and ask questions with AI
2025 Ohio 165 (El-Hitti v. Americare Kidney Inst., L.L.C.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.